Fersisi BACTERIOPHAGE Ungventum
Name of the pharmaceutical product (Patentable):
Fersisi bacteriophage is a sterile filtrate of phage lysates to
- Staphylococcus (S. aureus, S. epidermidis) titter no less than 10ml.
- Streptococcus (S. pyogenes, S. sanguis, S. salivarius, S. agalactiae ) titter no less than 10ml.
Inactive ingredientsL Bacteriological growth medium, standard sodium saline. Chinazolin as a conservator.
Specific antibacterial solution
Fersisi Bacteriophage leads to a specific lysis of bacteria belonging to Staphylococci and Streptococci.
To be used with curative and prophylaxis aim in pyo-inflammatory and enteric infections caused by the above mentioned microorganisms.
Otolaryngological diseases: inflammation of the middle ear, tonsillitis, laryngitis, rhinitis, tracheltis, bronchitis, pneumonia, pleurisy.
Skin infections: furunculosis, carbunculosis, abscess, deep infitration and abscessing sycosis.
Surgical diseases: Abscess, wound infections, mastitis, osteomyelitis, phlegmon.
Inflammation of oral cavity: stomatitis, gingivitis etc.
Eye diseases: bacterial conjunctivitis: Secondary infections with thermal burns.
Urogenital and gynecologic infections: urethritis, cystitis, pyelonephritis, endometritis.
Enteric infections: gastroenterocolitis, cholecystitis, staphylococcal toxic infection, dysbacterioses.
Pyo- inflammatory disease in children (including newborns) prevention of postoperative periods and hospital infection.
Treatment should continue for 6-10 days.
There are no contraindications ever observed for FERSIS bacteriophage, The used of FERSIS bacteriophage does not exclude concomitant use of antibiotic, or any other medicine.
Packaging and Storage Conditions
20 Gramm ungventun
shelf life 6 month.
hidded from the day light
Distributed without prescription
Developed by: G.Eliava Institute of bacteriophage, Microbiology and virology.
P.S as these products are very new, packaging is not fully functional and they have some printing issues! Please follow our instructions here! Thank you